Search results for "HEPATITIS C VIRUS"

showing 10 items of 403 documents

A20 Sample preparation for whole-genome next-generation sequencing (NGS) of hepatitis C virus (HCV) routine RNA samples

2019

Abstract Next-generation sequencing (NGS) is a technique that can capture the variability of viral populations in transmission studies. The conventional sample preparation for NGS, based on amplicons, is a potential source of errors, derived from the variable affinity of specific primers for different viral variants and from irregular DNA polymerase efficiency. In this context, we propose a more reliable method for viral whole genome sample preparation, starting from nucleic acids obtained and stored with conventional procedures. Our goal was to obtain complete hepatitis C virus (HCV) genome sequences to subsequently perform extensive phylogenetic analyses. Additionally, we aimed to test th…

VirologyHepatitis C virusAbstract OverviewmedicineRNASample preparationBiologymedicine.disease_causeMicrobiologyVirologyGenomeDNA sequencingVirus Evolution
researchProduct

Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients.

2013

Background and aims: Lower 25-Hydroxyvitamin D (25[OH]D) serum lev- els have been associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients (G1CHC). In addition, a recent genome-wide study identified genetic variants (rs12785878, near dehydrocholesterol reduc- tase, DHCR7; rs10741657, near CYP2R1; and rs7041, near vitamin D binding protein, GC) affecting 25(OH)D serum levels in healthy populations. We aimed to assess the association between vitamin D serum levels and its genetic determinants, with the severity of liver fibrosis. Material and methods: Two hundred sixty patients with biopsy-proven G1CHC were consecutively evaluated. The 25(OH)D serum levels wer…

VitaminAdultLiver CirrhosisMaleSerummedicine.medical_specialtyOxidoreductases Acting on CH-CH Group DonorsGenotypeHepatitis C virusSingle-nucleotide polymorphismHepacivirusBiologyReductasemedicine.disease_causeGastroenterologychemistry.chemical_compoundFibrosisVirologyInternal medicineGenotypemedicineVitamin D and neurologyHumansVitamin DCytochrome P450 Family 2Chromatography High Pressure LiquidHCV VITAMIN D DHCR7Settore MED/12 - GastroenterologiaPolymorphism GeneticHepatologyVitamin D-Binding ProteinHepatitis C ChronicMiddle Agedmedicine.diseaseInfectious DiseaseschemistryImmunologyCholestanetriol 26-MonooxygenaseFemaleSteatosisJournal of viral hepatitis
researchProduct

Vitamin D and Osteoporosis in HIV/HCV Coinfected Patients: A Literature Review

2015

Vitamin D deficiency further increases the risk of osteoporosis in HIV-positive patients coinfected with hepatitis C virus (HCV); however, it is still unclear whether HCV-related increased fracture risk is a function of the severity of liver disease. The aim of this review was to identify studies on associative vitamin D deficiency patterns in high-risk populations such as HIV/HCV coinfected patients. We did this by searching MEDLINE and EMBASE databases, from inception to August 2014, and included bibliographies. The final 12 articles selected are homogeneous in terms of age but heterogeneous in terms of sample size, participant recruitment, and data source. Most of the HIV/HCV coinfected …

VitaminPathologymedicine.medical_specialtySettore MED/17 - Malattie InfettiveEndocrinology Diabetes and MetabolismHepatitis C virusOsteoporosisMEDLINEReview ArticleHIV/HCV coinfected patientS VITAMIN Dmedicine.disease_causelcsh:Diseases of the endocrine glands. Clinical endocrinologyvitamin D deficiencyLiver diseasechemistry.chemical_compoundEndocrinologyInternal medicinemedicineVitamin D and neurologylcsh:RC648-665Vitamin d supplementationEndocrine and Autonomic Systemsbusiness.industryvirus diseasesmedicine.diseasechemistrybusiness
researchProduct

S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-C-Virus (HCV) -Infektion“ : AWMF-Register-Nr.: 021/012

2018

biologybusiness.industryHepatitis C virusHepacivirusGastroenterologyMEDLINEMedizinHepatitis CVirus diseasesmedicine.disease_causemedicine.diseasebiology.organism_classificationVirologylanguage.human_languageRobert koch institutGerman03 medical and health sciences0302 clinical medicinemedicinelanguage030211 gastroenterology & hepatology030212 general & internal medicinebusiness
researchProduct

Prophylaxis, diagnosis and therapy of Hepatitis C Virus (HCV) infection : The German guidelines on the management of HCV infection

2010

business.industryHepatitis C virusMedizinGastroenterologyDrug resistanceHepatitis CHepatitis Bmedicine.diseasemedicine.disease_causeHepatitis DVirologyTransplantation03 medical and health sciences0302 clinical medicinePharmacotherapymedicine030211 gastroenterology & hepatology030212 general & internal medicineViral hepatitisbusinessZeitschrift für Gastroenterologie
researchProduct

Hepatitic C virus infection and autoimmunity : clinical features, diagnostic tools and therapeutical aspects

1995

Summary Since the genom of the hepatitis C virus (HCV) was detected the pathogenesis of a distinct group of chronic liver disease and some non-hepatic disorders of sofar unknown origin could be newly established. A wide variety of clinical features including vasculitis, glomerulonephritis, porphyria and rheumatoid-like symptoms may become apparant separately or in combination. HCV can be precipitated in cryoglobulins and tissue-related HCV was found in liver and kidney specimen, for instance. HCV-related cryoglobulinemia or circulating immune complexes often occur with vasculitis. Hematological changes may be present such as thrombocytopenia. A considerable amount of patients show circulati…

business.industrymedicine.medical_treatmentHepatitis C virusAutoantibodyImmunosuppressionDiseasemedicine.disease_causemedicine.diseaseChronic liver diseaseCryoglobulinemiaVirologyAutoimmunityInfectious DiseasesImmunologymedicineVasculitisbusinessMédecine et Maladies Infectieuses
researchProduct

Biochemical and Kinetic Analyses of NS5B RNA-Dependent RNA Polymerase of the Hepatitis C Virus

1998

The biochemical properties of the RNA-dependent RNA polymerase (RdRp) of the hepatitis C virus were analyzed. A hexahistidine affinity-tagged NS5B fusion protein was expressed with recombinant baculoviruses in insect cells and purified to near homogeneity. Enzymatic activity of the purified protein was inhibited by KCl or high concentrations of NaCl and was absolutely dependent on Mg2+, which could be replaced by Mn2+. NS5B was found to be processive and able to copy long heteropolymeric templates with an elongation rate of 150-200 nucleotides/min at 22 degreesC. Kinetic constants were determined for all four nucleoside triphosphates and different templates. In case of a heteropolymeric RNA…

chemistry.chemical_classificationHepatitis C virusvirusesRNARNA-dependent RNA polymeraseHepacivirusBiologyViral Nonstructural ProteinsRibonucleosidemedicine.disease_causeRNA-Dependent RNA PolymeraseMolecular biologySubstrate Specificitychemistry.chemical_compoundKineticsBiochemistrychemistryRNA polymeraseVirologymedicineHumansNucleotideNS5BNucleosideVirology
researchProduct

The optimal dose of ribavirin for chronic hepatitis C: From literature evidence to clinical practice: The optimal dose of ribavirin for chronic hepat…

2010

Approximately 170 million people worldwide are chronically infected by hepatitis C virus (HCV), which can result in progressive hepatic injury and fibrosis, culminating in cirrhosis and end-stage liver disease. The benchmark therapy for untreated HCV patients is a combination of pegylated interferon-alpha (PEG-IFN) and ribavirin (RBV). Several studies have suggested several potential new approaches to improve HCV therapy-optimization of the dose and duration of RBV therapy, accompanied by careful clinical management, is crucial in ensuring the greatest likelihood of a long response to therapy. RBV causes serious side effects, but in clinical practice, there are no alternatives for the treat…

dose-responseHepatitis C virusRibavirinReview ArticleHepatitis monthly
researchProduct

A randomized controlled trial of high-dose maintenance interferon therapy in chronic hepatitis C

1997

In chronic hepatitis C virus (HCV) infection, the rate of sustained response to interferon is low. We evaluated, in patients responding to a 26-week course of interferon, the effect of high-dose maintenance therapy in preventing relapse. Three hundred and ten patients with chronic HCV infection (38.3% with cirrhosis, 80.6% with HCV type 1) received interferon alfa-2b for 26 weeks (10 MU tiw for 8 weeks, then 5 MU tiw for 18 weeks). One hundred and twenty-four subjects (40%) normalized aminotransferases, and were allocated randomly either to continue on 5 MU tiw for a further 26 weeks (prolonged therapy group: 60 patients) or to stop interferon (brief therapy group: 64 patients). Fifty-two w…

education.field_of_studyChemotherapyCirrhosisbusiness.industryHepatitis C virusmedicine.medical_treatmentPopulationAlpha interferonmedicine.disease_causemedicine.diseaseVirologyInfectious DiseasesMaintenance therapyVirologymedicineAdverse effectbusinesseducationInterferon alfamedicine.drugJournal of Medical Virology
researchProduct

Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy

2011

hepatitis C virus infection chronic kidney disease conservative therapy
researchProduct